|
|
| Accelerating genomic medicine | Traditional cell therapy manufacturing is hitting a logistical plateau that restricts patient access worldwide. Discover how the concept of the body as a bioreactor could shift the paradigm from external engineering to internal healing. Learn more |
|
|
|
|
In this Advancing RNA Live clip, CPI’s Claire McCleod shares the biological and logistical hurdles currently keeping full enzymatic production of siRNA at bay. |
|
|
|
|
|
|
|
|
|
|
|
|
| The 5th In Vivo Cell Engineering & Gene Editing Summit brings together leading scientists, biopharma innovators, and industry strategists to advance the next generation of in vivo delivery and editing technologies. With growing momentum behind extrahepatic targeting, early clinical readouts, and scalable manufacturing, this meeting offers critical insights to accelerate IND enabling work and shape the future of accessible, durable in vivo therapies. Register now |
|
|
|
|
|
|
|
.png){kind=logo}
